US Patent Issued to BREXOGEN on Dec. 9 for "Composition for preventing or treating renal diseases, comprising exosomes derived from precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells" (South Korean Inventors)

ALEXANDRIA, Va., Dec. 9 -- United States Patent no. 12,491,212, issued on Dec. 9, was assigned to BREXOGEN INC. (Seoul, South Korea).

"Composition for preventing or treating renal diseases, comprising exosomes derived from precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells" was invented by Sue Kim (Seoul, South Korea) and Seul Ki Lee (Gyeonggi-do, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical composition for preventing or treating renal diseases, comprising, as an active ingredient, exosomes isolated from precursor cells of induced pluripotent stem cell-derived mesenchymal stem cells, the precursor cells having been t...